Phase III Clinical Trials CROs
83 published
83 published CROs match Phase III Clinical Trials.
Locations in this set include United States, India, United Kingdom, Australia, China, and France.
Capabilities that show up most often in this set: Small Molecule, Biologics (Other), Gene Therapy, Cell Therapy, and Vaccine.
Matching companies
MMS HoldingsData-focused CRO providing full-spectrum biometrics, regulatory submissions, safety & risk management, and therapeutic expertise across oncology, CNS, rare diseases, and psychedelics. Named Best Specialist CRO at the Scrip Awards with zero refusals to file on 50+ marketing applications in five years.
MPREXMPREX is a contract research organization in Pune, India, specializing in clinical trials in dermatology and claim-substantiation studies for skin and hair care products, with laboratory testing for product efficacy and safety.
Medidata SolutionsMedidata provides a unified clinical trial platform with AI-driven data management, electronic data capture, patient engagement tools, and real-world data integration to accelerate research across all trial phases.
MedpaceFull-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit.
NovotechGlobal full-service CRO specializing in early-phase and oncology trials across 50+ countries, with expertise in cardiovascular, cell and gene therapy, and radiopharmaceutical development.
ObvioHealthObvioHealth delivers decentralized and hybrid clinical trial solutions through its ObvioGo platform, enabling sponsors to simplify study design, boost participant engagement, and accelerate enrollment across 40 countries.
PCM TrialsWorld's largest independent, community-based clinical trial site network offering decentralized and mobile research services across diverse patient populations globally.
PPDPPD is a leading global contract research organization (CRO) and the clinical research business of Thermo Fisher Scientific.
PSIPSI runs full-service Phase 2 and 3 clinical trials with a stated focus on on-time enrollment and over 90% repeat and referral business. Key therapeutic areas include oncology, GI, hematology, cell and gene therapy, neurology, and infectious diseases.
ParexelParexel is a comprehensive CRO offering end-to-end biopharmaceutical development services spanning portfolio optimization, early development, integrated clinical development, regulatory approval, and lifecycle value substantiation.
PerceptiveLeading clinical research organization providing preclinical to late-phase imaging, randomization and trial supply management (RTSM), and eClinical services to the global biopharmaceutical industry.
PharPoint ResearchPharPoint is a US-based CRO specializing in Phase I–IV clinical trials with rapid biometrics timelines, delivering database locks within 5 days of last patient visit and topline results in 2 business days.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
Premier ResearchPremier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
ProRelix ResearchProRelix Research supports Phase 1–4 clinical trials across pharmaceutical, biotechnology, and medical device sectors, offering clinical trial project management, data management, and medical writing services in compliance with ICH and GCP principles across the US, India, Europe, and Australia.
ProScientoSpecialized CRO focused on metabolic diseases (obesity, diabetes, MASLD/MASH, cardiovascular, chronic kidney disease) with two decades of expertise, a nationwide registry of 180,000+ participants, and full-service clinical development capabilities from Phase 1 through Phase 3.
ProtheragenSpecialized preclinical CRO dedicated to obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.
Proxima Clinical ResearchProxima Clinical Research provides integrated regulatory, clinical, and quality solutions for life science companies, with expertise across device and therapeutic development pathways including IDE, 510(k), IND, NDA, and BLA submissions.
QPSQPS provides integrated contract research and clinical services spanning bioanalysis, preclinical development, and early-to-late phase clinical trials across multiple therapeutic areas including oncology, dermatology, and women's health.
Raptim ResearchBioequivalence and bioavailability specialist with 32+ USFDA inspections cleared, running healthy-subject BA/BE and PK/PD studies, IVRT/IVPT in-vitro release and permeability testing, and Phase I to IV clinical trials.
Markdown mirror: /services/phase-3-clinical-trials.md